Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous Malformation

NCT: NCT07687472 · NOT_YET_RECRUITING

NCT IDNCT07687472
StatusNOT_YET_RECRUITING
Start Date2026-10-01
Completion2033-09-30
SponsorKaneka Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multicenter, post-market clinical follow-up (PMCF) study to collect safety and performance data in patients with arteriovenous malformations (AVMs) who undergo endovascular coil embolization using the i-ED Coil and Electro Detach Generator v4 (EDG v4).

Frequently Asked Questions

What is Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous Malformation?

Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous Malformation is a clinical trial registered under NCT07687472. Current status: NOT_YET_RECRUITING.

What is the status of NCT07687472?

The current status of NCT07687472 (Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous Malformation) is: NOT_YET_RECRUITING.

When did Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous Malformation start?

Post-Market Clinical Follow-up Study of i-ED Coil and EDG v4 for Arteriovenous Malformation started on 2026-10-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.